124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice.
暂无分享,去创建一个
Sanjiv S Gambhir | Arion F Chatziioannou | Gobalakrishnan Sundaresan | Paul J Yazaki | Anna M Wu | Steven M Larson | Ronald D Finn | S. Larson | S. Gambhir | A. Chatziioannou | G. Sundaresan | A. Wu | J. Shively | R. Finn | L. Williams | Andrew A Raubitschek | P. Yazaki | A. Raubitschek | Lawrence E Williams | John E Shively
[1] A. George,et al. Single-chain Fv radioimmunotargeting. , 1996, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.
[2] R. Leahy,et al. High-resolution 3D Bayesian image reconstruction using the microPET small-animal scanner. , 1998, Physics in medicine and biology.
[3] D. Goldenberg. Carcinoembryonic antigen as a target cancer antigen for radiolabeled antibodies: prospects for cancer imaging and therapy. , 1995, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
[4] K S Pentlow,et al. Quantitative imaging of I-124 using positron emission tomography with applications to radioimmunodiagnosis and radioimmunotherapy. , 1991, Medical physics.
[5] S. Rubin,et al. High-resolution positron emission tomography of human ovarian cancer in nude rats using 124I-labeled monoclonal antibodies. , 1993, Gynecologic oncology.
[6] D. King,et al. High-Level Expression of a Recombinant Antibody from Myeloma Cells Using a Glutamine Synthetase Gene as an Amplifiable Selectable Marker , 1992, Bio/Technology.
[7] T Jones,et al. Quantitative measurement of monoclonal antibody distribution and blood flow using positron emission tomography and 124iodine in patients with breast cancer , 1991, International journal of cancer.
[8] Michael E. Phelps,et al. Quantitation in Positron Emission Computed Tomography , 1980 .
[9] Paul Kinahan,et al. Analytic 3D image reconstruction using all detected events , 1989 .
[10] L E Williams,et al. Minibody: A novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts. , 1996, Cancer research.
[11] A. Riggs,et al. Cloning of the genes for T84.66, an antibody that has a high specificity and affinity for carcinoembryonic antigen, and expression of chimeric human/mouse T84.66 genes in myeloma and Chinese hamster ovary cells. , 1990, Cancer research.
[12] S. Cherry,et al. Performance evaluation of microPET: a high-resolution lutetium oxyorthosilicate PET scanner for animal imaging. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[13] T. Yokota,et al. Microautoradiographic analysis of the normal organ distribution of radioiodinated single-chain Fv and other immunoglobulin forms. , 1993, Cancer research.
[14] N. Volkow,et al. PET scanning of iodine-124-3F9 as an approach to tumor dosimetry during treatment planning for radioimmunotherapy in a child with neuroblastoma. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[15] S. Batra,et al. Effects of genetic engineering on the pharmacokinetics of antibodies. , 1999, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.
[16] R. Finn,et al. Low energy cyclotron production and chemical separation of "no carrier added" iodine-124 from a reusable, enriched tellurium-124 dioxide/aluminum oxide solid solution target , 2000 .
[17] Y. Arano. Strategies to reduce renal radioactivity levels of antibody fragments. , 1998, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.
[18] A. Wu,et al. Expression, purification, and characterization of a two domain carcinoembryonic antigen minigene (N-A3) in pichia pastoris. The essential role of the N-domain. , 1998, Anticancer research.
[19] P. Hand,et al. Biological properties of chimeric domain-deleted anticarcinoma immunoglobulins. , 1995, Cancer research.
[20] A. Scott,et al. Immuno-PET of human colon xenograft- bearing BALB/c nude mice using 124I-CDR-grafted humanized A33 monoclonal antibody. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[21] K S Pentlow,et al. Quantitative imaging of iodine-124 with PET. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[22] E. Hoffman,et al. Quantitation in Positron Emission Computed Tomography: 1. Effect of Object Size , 1979, Journal of computer assisted tomography.
[23] A A Raubitschek,et al. Mammalian expression and hollow fiber bioreactor production of recombinant anti-CEA diabody and minibody for clinical applications. , 2001, Journal of immunological methods.
[24] S S Gambhir,et al. High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[25] R. Ott,et al. c-erbB2 protein overexpression in breast cancer as a target for PET using iodine-124-labeled monoclonal antibodies. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[26] A. Wu,et al. Designer genes: recombinant antibody fragments for biological imaging. , 2000, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.